https://www.gyruscapital.com/news/accenture-completes-acquisition-of-lntellera-consulting 2026-03-18T11:04:20+00:00 weekly 0.8 https://www.gyruscapital.com/news/gyrus-capital-acquires-a-majority-stake-in-acbc-1 2026-03-18T11:04:23+00:00 weekly 0.8 https://www.gyruscapital.com/news/stepstone-group-provides-liquidity-solution-to-gyrus-capitals-lps-in-a-multi-asset-secondary-transaction-involving-dss-and-essential-pharma 2026-03-18T11:04:25+00:00 weekly 0.8 https://www.gyruscapital.com/news/gyrus-capital-raises-eur600m-continuation-fund 2026-03-18T11:04:27+00:00 weekly 0.8 https://www.gyruscapital.com/news/gyrus-capital-investment-into-neo-medical 2026-03-18T11:04:29+00:00 weekly 0.8 https://www.gyruscapital.com/news/dss-acquires-global-infrastructure-advisory-firm-infrata 2026-03-18T11:04:31+00:00 weekly 0.8 https://www.gyruscapital.com/news/lre-medical-announces-appointment-of-new-chief-executive-officer 2026-03-18T11:04:33+00:00 weekly 0.8 https://www.gyruscapital.com/news/homnya-announces-acquisition-of-editoriale-giornalidea 2026-03-18T11:04:37+00:00 weekly 0.8 https://www.gyruscapital.com/news/gyrus-capital-agrees-to-sell-intellera-to-accenture-nyse-acn 2026-03-18T11:04:39+00:00 weekly 0.8 https://www.gyruscapital.com/news/essential-pharma-acquires-renaissance-pharma-ltd-with-its-clinical-stage-immunotherapy-for-the-treatment-of-high-risk-neuroblastoma-2-apr-2024 2026-03-18T11:04:41+00:00 weekly 0.8 https://www.gyruscapital.com/news/intellera-expands-internationally-with-the-acquisition-of-predictby-in-spain 2026-03-18T11:04:43+00:00 weekly 0.8 https://www.gyruscapital.com/news/essential-pharma-acquires-european-rights-to-colobreathe-colistimethate-sodium-from-teva 2026-03-18T11:04:45+00:00 weekly 0.8 https://www.gyruscapital.com/news/gyrus-capital-holds-final-close-on-gyrus-capital-fund-ii 2026-03-18T11:04:47+00:00 weekly 0.8 https://www.gyruscapital.com/news/intellera-consulting-acquires-trust4value-to-grow-on-artificial-intelligence-and-machine-learning 2026-03-18T11:04:49+00:00 weekly 0.8 https://www.gyruscapital.com/news/dss-acquires-ads-system-safety-consulting 2026-03-18T11:04:52+00:00 weekly 0.8 https://www.gyruscapital.com/news/essential-pharma-appoints-lee-morley-as-non-executive-director-to-the-board 2026-03-18T11:04:53+00:00 weekly 0.8 https://www.gyruscapital.com/news/gyrus-capital-agrees-to-acquire-lre-medical-from-ais-global 2026-03-18T11:04:55+00:00 weekly 0.8 https://www.gyruscapital.com/news/inflexion-acquires-majority-stake-in-dss-from-gyrus-capital 2026-03-18T11:04:57+00:00 weekly 0.8 https://www.gyruscapital.com/news/essential-pharma-announces-the-acquisition-of-haldol 2026-03-18T11:05:01+00:00 weekly 0.8 https://www.gyruscapital.com/news/gyrus-acquires-40-of-consulcesi-group 2026-03-18T11:05:02+00:00 weekly 0.8 https://www.gyruscapital.com/news/gyrus-capital-to-acquire-consulcesi-group-with-founder-management 2026-03-18T11:05:04+00:00 weekly 0.8 https://www.gyruscapital.com/news/gyrus-capital-to-acquire-majority-stake-in-katalist-group 2026-03-18T11:05:06+00:00 weekly 0.8 https://www.gyruscapital.com/news/dss-acquires-perfect-food-consulting 2026-03-18T11:05:08+00:00 weekly 0.8 https://www.gyruscapital.com/news/dupont-sustainable-solutions-unveils-new-brand-name-dss 2026-03-18T11:05:10+00:00 weekly 0.8 https://www.gyruscapital.com/news/corcym-announces-growth-financing-to-accelerate-international-expansion-and-strategic-growth-initiatives 2026-03-18T11:05:12+00:00 weekly 0.8 https://www.gyruscapital.com/news/essential-pharma-completes-refinancing-and-two-significant-ma-transactions 2026-03-18T11:05:14+00:00 weekly 0.8 https://www.gyruscapital.com/news/dupont-sustainable-solutions-announces-new-members-to-board-of-directors 2026-03-18T11:05:16+00:00 weekly 0.8 https://www.gyruscapital.com/news/gyrus-capital-backed-dupont-sustainable-solutions-acquires-sofies-group 2026-03-18T11:05:18+00:00 weekly 0.8 https://www.gyruscapital.com/news/gyrus-capital-closes-debut-gyrus-investment-programme 2026-03-18T11:05:49+00:00 weekly 0.8 https://www.gyruscapital.com/news/gyrus-capital-holds-eur700m-final-close-on-continuation-fund 2026-03-18T11:05:51+00:00 weekly 0.8 https://www.gyruscapital.com/news/xaviera-arneodo-nallet-to-its-executive-gyrus-capital-announces-the-addition-of-xaviera-arneodo-nallet-to-its-executive-team 2026-03-18T11:05:53+00:00 weekly 0.8 https://www.gyruscapital.com/news/dss-acquires-proaction-international 2026-03-18T11:05:55+00:00 weekly 0.8 https://www.gyruscapital.com/news/fda-approves-lancelot-technology-for-perceval-plus 2026-03-18T12:07:42+00:00 weekly 0.8 https://www.gyruscapital.com/news/corcym-acquires-haart-aortic-annuloplasty-devices 2026-03-18T12:07:45+00:00 weekly 0.8 https://www.gyruscapital.com/news/acbc-announces-a-strategic-partnership-with-maxima-design 2026-03-18T12:07:47+00:00 weekly 0.8 https://www.gyruscapital.com/news/essential-pharma-further-expands-rare-disease-platform-through-acquisition-of-ventavis 2026-02-24T15:25:35+00:00 weekly 0.8 https://www.gyruscapital.com/news/renaissance-pharma-secures-fda-fast-track-designation-and-ind-clearance-for-daretabart 2026-04-14T13:12:06+00:00 weekly 0.8 https://www.gyruscapital.com/news/dss-acquires-lauras-international-usa 2026-06-09T15:47:06+00:00 weekly 0.8